ANKRD26 Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the ANKRD26 gene, its protein product, associated diseases, expression patterns, and mutational landscape.

Gene Information Card

Symbol ANKRD26
Full Name Ankyrin Repeat Domain 26
Gene Type Protein-coding
Chromosomal Location 10p12.1
NCBI Gene ID 57211 ncbi.nlm.nih.gov/gene/57211
Ensembl ID ENSG00000120068
UniProt ID Q9P2X0
OMIM ID 610855
HGNC ID 29186
Aliases bA145E17.1, MGC126562, MGC126564

Description

The ANKRD26 gene encodes a protein containing ankyrin repeats, which are involved in protein-protein interactions. It is located on chromosome 10p12.1 and is expressed in various tissues. Mutations in ANKRD26 are primarily associated with autosomal dominant thrombocytopenia (THC2), characterized by low platelet counts and a predisposition to leukemia. The protein is thought to play a role in hematopoiesis and megakaryocyte differentiation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thrombocytopenia 2 (THC2) Missense mutations in the 5' untranslated region (UTR) of ANKRD26 lead to increased ANKRD26 expression, which disrupts megakaryocyte differentiation and platelet production. ClinVar, OMIM
Myeloproliferative neoplasms Germline ANKRD26 mutations are associated with a predisposition to myeloid malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). OMIM, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Bone Marrow High High expression in hematopoietic tissues
Spleen Medium Moderate expression
Lymph Node Medium Moderate expression
Liver Low Low expression
Brain Low Low expression
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) High Chronic myeloid leukemia cell line
HEK293 (embryonic kidney) Medium Commonly used cell line
HeLa (cervical cancer) Low Low expression
MCF7 (breast cancer) Low Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.-118C>T 5' UTR variant Found in THC2 families Increases ANKRD26 expression
c.-127A>G 5' UTR variant Found in THC2 families Increases ANKRD26 expression
c.-134G>A 5' UTR variant Found in THC2 families Increases ANKRD26 expression
c.-140C>G 5' UTR variant Found in THC2 families Increases ANKRD26 expression
Mutation functional classification

Loss of Function (LOF)

Not commonly reported; loss-of-function mutations are not a major mechanism for ANKRD26-related diseases.

Gain of Function (GOF)

5' UTR mutations are gain-of-function, leading to overexpression of ANKRD26, which impairs megakaryocyte differentiation.

Dominant Negative (DN)

Not reported for ANKRD26.

Gene Ontology (GO)

• protein binding • ankyrin repeat binding
• cytoplasm • nucleus
• regulation of megakaryocyte differentiation

Pathways

Megakaryocyte differentiation
Hematopoiesis
MAPK signaling pathway (potential involvement)

Protein Summary

The ANKRD26 protein contains ankyrin repeats, which are common motifs for protein-protein interactions. It is localized in the cytoplasm and nucleus. The protein is involved in the regulation of hematopoiesis, particularly megakaryocyte differentiation. Overexpression of ANKRD26 due to 5' UTR mutations disrupts this process, leading to thrombocytopenia and increased risk of leukemia.

Related Products

Product name Cat.No. Species Gene ID
ANKRD26 Knockout HEK293 Cell Line EDJ-KQ7694 Human 22852 Details Get a Quote
ANKRD26 Knockout HCT 116 Cell Line EDJ-KQ33066 Human 22852 Details Get a Quote
ANKRD26 Knockout HeLa Cell Line EDJ-KQ33067 Human 22852 Details Get a Quote
ANKRD26 Knockout A-549 Cell Line EDJ-KQ31742 Human 22852 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: